Charles River Laboratories Announces First-Quarter 2019 Results

Go back to Charles River Laboratories Announces First-Quarter 2019 Results

Charles River Laboratories (CRL) Tops Q1 EPS by 2c, Reaffirms 2019 Guidance

May 7, 2019 7:08 AM EDT

Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $604.6 million versus the consensus estimate of $595.66 million.

The Company is reaffirming its revenue growth and non-GAAP earnings per share guidance for 2019... More